Catalog |
name |
Description |
price |
R-L-150 |
Recombinant Human Copper,Zinc- Superoxide |
Recombinant Human Cu/Zn SOD1 produced in E. coli is a homodimer non-glycosylated polypeptide chain containing 2 x 154 amino acids with a molecular weight of 31.6kDa. |
price> |
R-R-0309 |
NOTA-NFB |
NOTA-NFB is a very useful peptide labeling reagent that can label proteins or other biomolecules with groups with specific functions. By using NOTA-NFB, it is easier to study the function and behavior of biomolecules, as well as their interactions with other molecules. |
price> |
R-R-0311 |
DOTA-JR-11 |
DOTA-JR11 is a somatostatin receptor 2(SSTR2)antagonist. DOTA-JR11 can be labeled by 68Ga, used for paired imaging in neuroendocrine tumors (NETs) research. |
price> |
R-R-0312 |
DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 |
DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2, also known as DOTA-E[c(RGDfK)]2, is a radiolabeled peptide-based compound used in molecular imaging and targeted therapy. It is a specific molecule designed to target integrin receptors, which are proteins found on the surface of cells, often overexpressed in tumors and involved in processes such as tumor growth, angiogenesis, and metastasis. |
price> |
R-R-0316 |
NOTA-P2-RM26 |
NOTA-P2-RM26 is a peptide-based compound used in molecular imaging and targeted therapy for prostate cancer. NOTA-P2-RM26 represents a promising tool for the molecular imaging and targeted therapy of prostate cancer, offering potential applications in diagnosis, staging, and personalized treatment of this disease. |
price> |
R-R-0319 |
Dota-ggga |
Dota-ggga, also known as D-ggga CAS:149206-86-0, is a chemical compound that has recently gained attention in the scientific community due to its potential therapeutic applications. This compound has been found to have a unique mechanism of action that makes it a promising candidate for the treatment of various diseases. |
price> |
R-R-0325 |
cyclic Arg(Pbf)-Gly-Asp(Ot-Bu)-D-Phe-Lys(NH2) |
Heterocyclic organic compound chelating agent cyclic Arg(Pbf)-Gly-Asp(Ot_Bu)-D-Phe-Lys(NH2)CAS:226559-04-2, RGD sequence peptide has a wide range of biological activities and refers to the three amino acids consisting of Arg-Gly-Asp. Sequence peptides are divided into linear peptides and cyclic peptides. |
price> |
R-R-0363 |
Balixafortide |
Balixafortide/CAS: 1051366-32-5(POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects. |
price> |
R-R-0364 |
Etelcalcetide hydrochloride |
Etelcalcetide hydrochloride (AMG 416 hydrochloride)/CAS: 1334237-71-6 is a synthetic peptide as an activator of the calcium sensing receptor (CaSR). Etelcalcetide hydrochloride is effective in lowering parathyroid hormone (PTH) concentrations in patients receiving dialysis with secondary hyperparathyroidism receiving hemodialysis. |
price> |
R-R-0367 |
Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) |
Cyclo(Arg-Gly-Asp-D-Tyr-Lys)CAS 217099-14-4 is a new synthetic peptide with anticancer activity. It has been shown to inhibit the growth of bladder cancer cells in vitro and in vivo, with no evidence of toxicity to normal bladder cells.Cyclo(Arg-Gly-Asp-D-Tyr-Lys) is a light sensitive molecule that can be delivered by an injection or as a pill. The peptide has been shown to have synergistic anticancer effects when combined with epirubicin, a chemotherapeutic drug used for the treatment of solid tumours, such as glioma and other cancers.Cyclo(Arg-Gly-Asp-D-Tyr-Lys) is also taken up by cells and causes DNA damage at the cellular level, leading to apoptosis. |
price> |